Noom Med is a medically-guided weight loss program that combines clinical care with Noom's behavior-change tools. The program provides virtual consultations, medication management, and nutrition ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

New research suggests that fasting for three days a week may lead to greater weight loss than slightly reducing calories ...

Lizzie Ens was shunned by her family after leaving home to start a new life at the age of 19 ...

Hims & Hers is down 30% but still a Buy: margin expansion, GLP-1 clarity, new hormone care, and global growth. Learn more about HIMS stock here.

GLP-1 medications are prescription treatments that require evaluation by a licensed clinician. Compounded medications are not FDA-approved as finished products. Always consult a qualified healthcare ...

A simple change in how primary care clinics approach weight management is delivering big public health wins. PATHWEIGH lets ...

Share on Pinterest The Food and Drug Administration (FDA) recently approved a tablet version of the GLP-1 drug Wegovy for weight loss. Image courtesy of Novo Nordisk Novo Nordisk officials said a new ...

A study by the financial firm Jefferies highlights a surprising perk for carriers: lower fuel costs as slimmer passengers ...

Bariatric surgery far outperformed GLP-1 weight loss drugs in a new real-world comparison of more than 50,000 patients. Two years after treatment, surgery patients lost about 58 pounds on average, ...

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

As the popularity of weight-loss drugs continues to boom, it has opened the door for scammers eager to dupe people into ...